We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Laryngeal Tubes Beat Intubation Following Heart Attack

By HospiMedica International staff writers
Posted on 11 Sep 2018
Patients with out-of-hospital cardiac arrest (OHCA) fare better with initial laryngeal tube (LT) insertion than endotracheal intubation (ETI), according to a new study.

Researchers at the University of Texas (UT) Health Science Center (UTH; Houston, USA), the U.S. More...
National Heart, Lung, and Blood Institute (NHLBI; Bethesda, MD, USA), and other institutions conducted a study involving 3,004 adults (median age 64 years, 60.9% men) who experienced OHCA and were treated by emergency medical service (EMS) agencies, including advanced airway management. The 27 EMS agencies were randomized to an initial airway management strategy involving LT (1,505 patients), or ETI (1,499 patients), with crossover to the alternate strategy at 3-5 month intervals. The primary outcome was 72-hour survival.

The results revealed that 72-hour survival was 18.3% in the LT group, compared to 15.4% in the ETI group. Secondary outcomes, including return of spontaneous circulation (ROSC), survival to hospital discharge, favorable neurological status at hospital discharge, and adverse events, showed a consistent superiority of LT over ETI. No major differences in airway swelling, oropharyngeal or hypopharyngeal injury, or pneumonia or pneumonitis were identified. Rates of initial airway success were 90.3% with LT and 51.6% with ETI. The study was published on August 28, 2018, in Journal of the American Medical Association (JAMA).

“During resuscitation, opening the airway and having proper access to it is a key factor for the survival of someone who goes into cardiac arrest outside of a hospital. But one of the burning questions in prehospital emergency care has been, ‘Which is the best airway device?’” said study co-author George Sopko, MD, MPH, of the NHLBI. “This study demonstrated that just by managing the airway well in the early stage of resuscitation, we could save more than 10,000 lives every year.”

Numerous studies have highlighted the challenges facing paramedic ETI, including significant rates of tube misplacement or dislodgement, need for multiple ETI attempts, and insertion failure. ETI has also been associated with iatrogenic hyperventilation and chest compression interruptions. Alternatives to ETI include supraglottic airway (SGA) devices, which include the LT, a laryngeal mask airway, esophageal-tracheal combitube, and others. While offering ventilatory characteristics similar to ETI, SGA insertion is rapid, simple, requires less training.

Related Links:
University of Texas Health Science Center
U.S. National Heart, Lung, and Blood Institute


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.